MeVis Medical Solutions AG (FRA:M3V)
24.80
0.00 (0.00%)
Last updated: Jul 31, 2025
Intra-Cellular Therapies Market Cap
FRA:M3V has a market cap or net worth of €45.14 million as of August 1, 2025. Its market cap has decreased by -2.36% in one year.
Market Cap
45.14M
Enterprise Value
42.57M
Revenue
16.64M
Ranking
n/a
PE Ratio
10.49
Stock Price
$24.80
Market Cap Chart
Since November 16, 2007, FRA:M3V's market cap has decreased from 64.22M to 45.14M, a decrease of -29.72%. That is a compound annual growth rate of -1.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 45.14M | -1.59% |
Dec 30, 2024 | 45.86M | - |
Dec 29, 2023 | 45.86M | -28.41% |
Dec 30, 2022 | 64.06M | 12.10% |
Dec 30, 2021 | 57.15M | -0.63% |
Dec 30, 2020 | 57.51M | 4.64% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 292.08B |
Siemens Aktiengesellschaft | 174.92B |
Deutsche Telekom AG | 153.20B |
Allianz SE | 132.59B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 79.52B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.53B |
Deutsche Bank Aktiengesellschaft | 55.70B |